Third-Party vs Industry-Funded CME
Not all medical education is created equal. Understanding who funds the content — and who controls it — is essential for physicians who want to make clinical decisions based on balanced, unbiased information.
Funding shapes content
The CME system was built on a premise: physicians need continuing education, and pharmaceutical companies have a legitimate interest in supporting it. In practice, the line between education and promotion can blur.
Research has consistently shown that industry-funded medical education tends to favor sponsors' products — not through overt promotion (ACCME standards prevent that), but through subtler choices: which data is emphasized, which competitor therapies are underweighted, which faculty are selected, which clinical scenarios are highlighted.
Third-party medical education is structured to eliminate these structural biases. The provider is accountable to physicians and learners — not to the companies whose therapies are discussed.
Six signals of truly independent CME
Who controls the content
An independent provider develops the educational content, selects faculty, and finalizes the curriculum — without sponsor input on clinical messaging.
A pharmaceutical or medical device company develops (or heavily shapes) the content, selects speakers aligned with their products, and controls the narrative.
Who selects the faculty
Faculty are chosen by the educational provider based on expertise, teaching ability, and balance — not their relationship with a sponsor.
Speakers are often on the sponsor's speaker bureau or advisory board, creating a structural bias even when individual speakers are credible.
What happens with off-label and competitor therapies
Balanced coverage of the full therapeutic landscape — including generics, off-label use, competitor products, and non-drug options.
Coverage tends to emphasize the sponsor's product and minimize or omit competitive alternatives. Off-label use of the sponsor's drug may be highlighted while competitors' off-label data is ignored.
Disclosure format
Clear upfront disclosure of funding sources, faculty conflicts of interest, and editorial independence from any sponsors.
Disclosures are often buried in fine print, and the sponsor's role in content development may be understated.
Scientific review process
Content undergoes independent scientific review before delivery. Reviewers have no financial stake in the therapeutic area.
Medical, legal, and regulatory (MLR) review by the sponsor's own team — optimized for regulatory compliance, not educational balance.
What "non-promotional" actually means
Content cannot promote any specific product. Clinical decisions, treatment sequencing, and risk/benefit are presented objectively.
The term "non-promotional" may be used, but when a sponsor funds and shapes content about their own therapeutic area, true balance is structurally difficult.
Industry-supported CME isn't all bad
Much of modern CME involves some form of industry support. ACCME-accredited providers can accept commercial grants as long as the sponsor has no editorial control over the content. In these cases, the line between "third-party" and "industry-supported" blurs — and the key question becomes how much independence the educational provider actually maintains.
The clearest third-party model is one where the educational provider develops content without input from any commercial sponsor, selects faculty independently, and funds its work through non-commercial means or through grants with explicit firewalls.
When evaluating a CME offering, the right question isn't just "is this free?" but "who funded this, who controlled the content, and how do I know?"
Third-party and non-promotional by design
Knowledge Med operates as an independent third-party medical education provider. Our content is developed without sponsor input, our faculty are selected for clinical expertise, and every session undergoes independent scientific review before delivery.
Sessions cover the full therapeutic landscape — all approved therapies, relevant off-label data, and evidence-based sequencing across sponsors and products. Because we answer to physicians, not to pharma.
More on medical education
How to Find Non-Promotional CME
Practical steps for identifying balanced medical education.
Live vs On-Demand CME
Which CME format actually changes practice?
Best Free CME for Oncologists
Quality free medical education in oncology.
Best Interactive Medical Education Platforms
Comparison of top platforms for physicians.
Experience Independent Medical Education
Third-party, non-promotional sessions led by faculty from leading academic medical centers. Free for community physicians.
Join a Session